Two-year prospective, randomized trial comparing an innovative twice-a-week progestin regimen with a continuous combined regimen as postmenopausal hormone therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/9935129

Download in:

View as

General Info

PMID
9935129